mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.02 |